The latest medical news on Transplant Pulmonology

Elevated metabolites of the kynurenine pathway found in PAH patients were predictors of disease severity, response to therapy, and survival.

Columnist and caregiver Colleen Steele offers tips and support to any caregivers going through a difficult period with their loved one.

For patients with chronic thromboembolic pulmonary hypertension or CTEPH, risk assessments did not predict treatment outcomes after surgery.

Columnist Colleen Steele, a longtime caregiver, realizes she's not so good at her own self-care, partly because of PTSD.

A Phase 3 trial in inoperable or persistent CTEPH patients in Japan found significant gains with Uptravi (selexipag) in blood flow measures.

Columnist Jen Cueva describes how a lunch with a rare disease colleague helped her embrace her disability.

Columnist Anna Jeter notes the myriad ways friends and a supportive community have helped in her years with pulmonary hypertension.

Most pulmonary arterial hypertension patients who start treatment with oral Opsumit (macitentan) are expected to be alive after nine years.

Echocardiograms during pregnancy to assess babies' heart function may help doctors predict persistent pulmonary hypertension in newborns.

Columnist Colleen Steele recounts a frightening morning of heart issues — all apparently caused by dehydration.

Yutrepia, an inhaled form of treprostinil, was preferred for the treatment of pulmonary arterial hypertension by patients in the INSPIRE trial

Nearly a third of 101 patients with COVID-19 in the study showed signs of pulmonary hypertension, which was linked to a higher mortality risk.